Alterity Therapeutics (ASX:ATH) doses first European patient in phase two MSA trial
Alterity Therapeutics (ATH) has dosed its first patient in Italy as part…
Alterity Therapeutics Limited (ASX:ATH)
About Alterity Therapeutics Limited
Key Information
ATH In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 18/04/2024 | Change in substantial holding | 416.97KB | 434 |
| 17/04/2024 | Alterity Parkinson's and MSA Data Featured at AAN Meeting | 279.47KB | 5.4K |
| 15/04/2024 | Application for quotation of securities - ATH | 15.77KB | 496 |
| 12/04/2024 | Options Prospectus | 396.89KB | 516 |
| 12/04/2024 | Results of Extraordinary General Meeting | 178.79KB | 421 |
| 10/04/2024 | Alterity to Present New ATH434 Data at Orphan Drug Congress | 266.37KB | 7.6K |
| 26/03/2024 | Price Sensitive PS Alterity Receives a $3.9 million R&D Tax Incentive Refund | 148.62KB | 1.0K |
| 25/03/2024 | Change in substantial holding | 1.5MB | 875 |